Immuno-, radio-, and chemotherapeutic studies in head and neck cancer. Highlights of the ASCO Annual Meeting 2017

被引：2

作者：

Schuler, P. J. ^{[1
]}

von Witzleben, A. ^{[1
]}

Doescher, J. ^{[1
]}

Wollenberg, B. ^{[2
]}

Dietz, A. ^{[3
]}

Hoffmann, T. K. ^{[1
]}

机构：

[1] Univ Klin Ulm, Klin Hals Nasen Ohrenheilkunde & Kopf Hals Chirur, Kopf Hals Tumorzentrum Ulm, Frauensteige 12, D-89070 Ulm, Germany

[2] Univ Klin Lubeck, Klin Hals Nasen Ohrenheilkunde & Kopf Hals Chirur, Kopf Hals Tumorzentrum Lubeck, Lubeck, Germany

[3] Univ Klin Leipzig, Klin Hals Nasen Ohrenheilkunde & Kopf Hals Chirur, Kopf Hals Tumorzentrum Leipzig, Leipzig, Germany

来源：

HNO | 2018年 / 66卷 / 03期

关键词：

Genome; Genetic structures; ASCO; Cell cyle checkpoints; Immunotherapy; SQUAMOUS-CELL CARCINOMA; RECURRENT;

D O I：

10.1007/s00106-018-0482-9

中图分类号：

R76 [耳鼻咽喉科学];

学科分类号：

100213 ;

摘要：

In recent years, immunotherapy has been shown to be a promising approach for the treatment of various tumor entities. Due to further pharmacological developments and new studies, the checkpoint inhibitors have now arrived in the clinic. To date, patients with cancers in the head and neck region have benefited from these agents as part of a palliative therapy. Current clinical trials are testing other indications for the checkpoint inhibitors as monotherapy or in combination with other therapeutic approaches. The following article summarizes the highlights of the American Society of Clinical Oncology (ASCO) Annual Meeting.

引用

页码：212 / 218

页数：7

共 40 条

[1] Immun-, radio- und chemotherapeutische Studien bei Kopf-Hals-TumorenHighlights der ASCO-Jahrestagung 2017Immuno-, radio-, and chemotherapeutic studies in head and neck cancerHighlights of the ASCO Annual Meeting 2017
P. J. Schuler
A. von Witzleben
J. Doescher
B. Wollenberg
A. Dietz
T. K. Hoffmann
HNO, 2018, 66 : 212 - 218
[2] Studies on radiotherapy of head and neck cancer Highlights of the 2019 ASCO Annual Meeting
Ott, S.
Wiegel, T.
Hoffmann, T. K.
Petersen, C.
Tribius, S.
Laban, S.
HNO, 2019, 67 (12) : 918 - 924
[3] Radiotherapeutic studies of head and neck cancer-highlights of the 2018 ASCO Annual Meeting
Ott, S.
Wiegel, T.
Laban, S.
Hoffmann, T. K.
Petersen, C.
Tribius, S.
HNO, 2018, 66 (12) : 901 - 906
[4] Immunotherapy for head and neck cancer Highlights of the 2019 ASCO Annual Meeting
Doescher, J.
Busch, C. -J.
Wollenberg, B.
Dietz, A.
Wuerdemann, N.
Schuler, P.
Hoffmann, T. K.
Laban, S.
HNO, 2019, 67 (12) : 905 - 911
[5] Highlights of the 2024 ASCO Annual Meeting: radiotherapy of head and neck cancer
Schnellhardt, Soeren
Tribius, Silke
Linxweiler, Maximilian
Gostian, Antoniu-Oreste
Hecht, Markus
HNO, 2024,
[6] Trials in head and neck cancer - Highlights of the ASCO Annual Meeting 2021
Wiegand, Susanne
Wichmann, Gunnar
Dietz, Andreas
LARYNGO-RHINO-OTOLOGIE, 2021, 100 (10) : 774 - 780
[7] Immunotherapeutic studies of head and neck tumors. Highlights of the 2016 ASCO Annual Meeting
Busch, C-J.
Laban, S.
Knecht, R.
Hoffmann, T. K.
HNO, 2016, 64 (10) : 708 - 716
[8] Current Treatment Concepts in Head and Neck Cancer Highlights of the 2016 ASCO Annual Meeting
Knecht, R.
HNO, 2016, 64 (10) : 699 - 699
[9] Systemic therapy for head and neck cancer-highlights of the 2024 ASCO Annual Meeting
Blaurock, Markus
Brunner, Cornelia
Busch, Chia-Jung
HNO, 2024, 72 (12) : 857 - 861
[10] Immunotherapy highlights of the ASCO annual meeting 2018 for head and neck cancers
Laban, S.
Doescher, J.
Busch, C. -J.
Wollenberg, B.
Dietz, A.
Wuerdemann, N.
Schuler, P. J.
Hoffmann, T. K.
HNO, 2018, 66 (12) : 880 - 887

← 1 2 3 4 →